Review of Guidelines on Bupropion for Depression (Last Updated: Oct 30, 2024)
Project Line:
Health Technology Review
Project Status:
Completed
Search
Health Technology Review
Remove
GLP-1 Receptor Agonists and Self-Harm (Last Updated: Oct 29, 2024)
The objective of this query is to investigate whether there is an increased risk of intentional self-harm following glucagon-like peptide-1 (GLP-1) receptor agonists, compared to sodium-glucose...
Project Line:
Health Technology Review
Project Status:
Active
Gabapentin for Seizures (Last Updated: Oct 25, 2024)
Project Line:
Health Technology Review
Project Status:
Completed
Early Biologic Treatment for Inflammatory Bowel Disease (Last Updated: Oct 25, 2024)
Project Line:
Health Technology Review
Project Status:
Completed
The Utilization of PCSK9 Inhibitors in Familial Hypercholesterolemia (Last Updated: Oct 22, 2024)
Familial hypercholesterolemia is a genetic disorder caused by homozygous or heterozygous mutations of the low-density lipoprotein receptor gene, apolipoprotein B gene, or PCSK9 gene. It is...
Project Line:
Health Technology Review
Project Status:
Active
Airway Management in Out-of-Hospital Emergencies (Last Updated: Oct 21, 2024)
Project Line:
Health Technology Review
Project Status:
Completed
BRAF and MEK Inhibitors for Active or Symptomatic Melanoma Brain Metastasis (Last Updated: Oct 21, 2024)
Project Line:
Health Technology Review
Project Status:
Completed
Re-treatment With Immune Checkpoint Inhibitors: Utilization Analysis (Last Updated: Oct 16, 2024)
Immune checkpoint inhibitors (ICIs), such as pembrolizumab and cemiplimab, are approved for various cancers. Both are typically administered for up to 2 years, with evidence supporting re-treatment...
Project Line:
Health Technology Review
Project Status:
In Progress
The Effectiveness of PCSK9 Inhibitors in Familial Hypercholesterolemia (Last Updated: Oct 10, 2024)
Familial hypercholesterolemia is a genetic disorder caused by homozygous or heterozygous mutations of the low-density lipoprotein receptor gene, apo B , or the PCSK9 gene. It is characterized by very...
Project Line:
Health Technology Review
Project Status:
Active
Bilateral Opportunistic Salpingectomy to Reduce the Incidence of Ovarian Cancer (Last Updated: Oct 4, 2024)
Project Line:
Health Technology Review
Project Status:
Completed